Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hyperplasia × Tirzepatide × Other × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Gynecologic 1

Conditions

Obesity 8 Endometrial Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Overweight 1 Metabolic Syndrome 1 Insulin Resistance 1 Inflammation 1 Hyperplasia 1 Endometrial Hyperplasia 1 Dyslipidemias 1 Diabetes Mellitus 1 Colorectal Neoplasms 1 Breast Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07078838 2026-01-16

Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 2 Not yet recruiting

GynecologicOther

Endometrial Hyperplasia, Hyperplasia, Obesity, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡